BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21813396)

  • 1. Large regenerative nodules in a patient with Budd-Chiari syndrome after TIPS positioning while on the liver transplantation list diagnosed by Gd-EOB-DTPA MRI.
    Renzulli M; Lucidi V; Mosconi C; Quarneti C; Giampalma E; Golfieri R
    Hepatobiliary Pancreat Dis Int; 2011 Aug; 10(4):439-42. PubMed ID: 21813396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of Budd-Chiari syndrome: Gd-EOB-DTPA-enhanced MR findings.
    Kitajima K; Yoshikawa T; Seo Y; Ohno Y; Yano Y; Miki A; Kanda T; Kanata N; Azuma T; Sugimura K
    Magn Reson Imaging; 2011 May; 29(4):579-83. PubMed ID: 21216550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transjugular intrahepatic portosystemic shunt for severe jaundice in patients with acute Budd-Chiari syndrome.
    He FL; Wang L; Zhao HW; Fan ZH; Zhao MF; Dai S; Yue ZD; Liu FQ
    World J Gastroenterol; 2015 Feb; 21(8):2413-8. PubMed ID: 25741149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of chronic Budd-Chiari syndrome with a transjugular intrahepatic portosystemic shunt.
    Michl P; Bilzer M; Waggershauser T; Gülberg V; Rau HG; Reiser M; Gerbes AL
    J Hepatol; 2000 Mar; 32(3):516-20. PubMed ID: 10735624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Hypervascular Hypointense Hepatic Nodules during the Hepatobiliary Phase of Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI as a Risk Factor of Intrahepatic Distant Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma.
    Iwamoto T; Imai Y; Igura T; Kogita S; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Ohashi H; Fujita N; Kudo M; Takehara T
    Dig Dis; 2017; 35(6):574-582. PubMed ID: 29040990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI as a predictor of outcomes for early-stage HCC.
    Toyoda H; Kumada T; Tada T; Sone Y; Maeda A; Kaneoka Y
    Hepatol Int; 2015 Jan; 9(1):84-92. PubMed ID: 25788383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of TIPS as a bridge to hepatic transplantation in Budd-Chiari syndrome.
    Ryu RK; Durham JD; Krysl J; Shrestha R; Shrestha R; Everson GT; Stephens J; Kam I; Wachs M; Kumpe DA
    J Vasc Interv Radiol; 1999 Jun; 10(6):799-805. PubMed ID: 10392951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multiple regeneration nodes in the temporal follow-up of Budd-Chiari syndrome after TIPS].
    Pennekamp W; Willert J; Wittl E
    Rofo; 2011 Mar; 183(3):288-90. PubMed ID: 21113869
    [No Abstract]   [Full Text] [Related]  

  • 9. Budd-Chiari syndrome/hepatic venous outflow tract obstruction.
    Valla DC
    Hepatol Int; 2018 Feb; 12(Suppl 1):168-180. PubMed ID: 28685257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-enhanced MR angiography of benign regenerative nodules following TIPS shunt procedure in Budd-Chiari syndrome.
    Tanju S; Erden A; Ceyhan K; Soygür IT; Bozkaya H; Erden I
    Turk J Gastroenterol; 2004 Sep; 15(3):173-7. PubMed ID: 15492917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of non-hypervascular hypointense nodules on Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma.
    Inoue M; Ogasawara S; Chiba T; Ooka Y; Wakamatsu T; Kobayashi K; Suzuki E; Tawada A; Yokosuka O
    J Gastroenterol Hepatol; 2017 Apr; 32(4):908-915. PubMed ID: 27787908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-hypervascular hypointense nodules detected by Gd-EOB-DTPA-enhanced MRI are a risk factor for recurrence of HCC after hepatectomy.
    Toyoda H; Kumada T; Tada T; Niinomi T; Ito T; Sone Y; Kaneoka Y; Maeda A
    J Hepatol; 2013 Jun; 58(6):1174-80. PubMed ID: 23376360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utility of TIPS in the management of Budd-Chiari syndrome.
    Molmenti EP; Segev DL; Arepally A; Hong J; Thuluvath PJ; Rai R; Klein AS
    Ann Surg; 2005 Jun; 241(6):978-81; discussion 982-3. PubMed ID: 15912047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of transjugular intrahepatic portosystemic shunt in Indian patients with Budd-Chiari syndrome.
    Shalimar ; Gamanagatti SR; Patel AH; Kedia S; Nayak B; Gunjan D; Ranjan G; Paul SB; Acharya SK
    Eur J Gastroenterol Hepatol; 2017 Oct; 29(10):1174-1182. PubMed ID: 28763339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transjugular intrahepatic cavoportal shunt for Budd-Chiari syndrome.
    Ul Haq T; Munir K; Haider Z; Yaqoob J; Usman U
    Australas Radiol; 2005 Apr; 49(2):140-3. PubMed ID: 15845052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transjugular intrahepatic portosystemic shunt for the treatment of Budd-Chiari syndrome patients: results from a single center.
    Fitsiori K; Tsitskari M; Kelekis A; Filippiadis D; Triantafyllou K; Brountzos E
    Cardiovasc Intervent Radiol; 2014 Jun; 37(3):691-7. PubMed ID: 23860938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Budd-Chiari Syndrome and hepatic regenerative nodules: Magnetic resonance findings with emphasis of hepatobiliary phase.
    Mamone G; Carollo V; Di Piazza A; Cortis K; Degiorgio S; Miraglia R
    Eur J Radiol; 2019 Aug; 117():15-25. PubMed ID: 31307641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions.
    Hammerstingl R; Huppertz A; Breuer J; Balzer T; Blakeborough A; Carter R; Fusté LC; Heinz-Peer G; Judmaier W; Laniado M; Manfredi RM; Mathieu DG; Müller D; Mortelè K; Reimer P; Reiser MF; Robinson PJ; Shamsi K; Strotzer M; Taupitz M; Tombach B; Valeri G; van Beers BE; Vogl TJ;
    Eur Radiol; 2008 Mar; 18(3):457-67. PubMed ID: 18058107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: A comprehensive review.
    Inchingolo R; Posa A; Mariappan M; Tibana TK; Nunes TF; Spiliopoulos S; Brountzos E
    World J Gastroenterol; 2020 Sep; 26(34):5060-5073. PubMed ID: 32982109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up after successful transjugular intrahepatic portosystemic shunt placement in a pediatric patient with Budd-Chiari syndrome.
    Carnevale FC; Szejnfeld D; Moreira AM; Gibelli N; De Gregório MA; Tannuri U; Cerri GG
    Cardiovasc Intervent Radiol; 2008; 31(6):1244-8. PubMed ID: 18756372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.